CD19 and congenital rubella syndrome: One of the largest retrospective cohort studies examined CMV infections in 230 CD19 CAR-T recipients over a 3-year period, with weekly plasma CMV PCR performed in patients with neutropenia or those with grade 3/4 CRS/ICANS for up to one month after CAR-T [24].